Clinical Trial Update: The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial from Vanderbilt evaluated the impact of Factor Xa inhibition on thrombosis, platelet activation, and endothelial function in peripheral a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Factor Xa inhibitor (unspecified)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Peripheral Arterial Disease | Phase 4 | Status: COMPLETED